X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
77
PharmaCompass offers a list of Cisatracurium Besylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cisatracurium Besylate manufacturer or Cisatracurium Besylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cisatracurium Besylate manufacturer or Cisatracurium Besylate supplier.
PharmaCompass also assists you with knowing the Cisatracurium Besylate API Price utilized in the formulation of products. Cisatracurium Besylate API Price is not always fixed or binding as the Cisatracurium Besylate Price is obtained through a variety of data sources. The Cisatracurium Besylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cisatracurium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cisatracurium, including repackagers and relabelers. The FDA regulates Cisatracurium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cisatracurium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cisatracurium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cisatracurium supplier is an individual or a company that provides Cisatracurium active pharmaceutical ingredient (API) or Cisatracurium finished formulations upon request. The Cisatracurium suppliers may include Cisatracurium API manufacturers, exporters, distributors and traders.
click here to find a list of Cisatracurium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cisatracurium DMF (Drug Master File) is a document detailing the whole manufacturing process of Cisatracurium active pharmaceutical ingredient (API) in detail. Different forms of Cisatracurium DMFs exist exist since differing nations have different regulations, such as Cisatracurium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cisatracurium DMF submitted to regulatory agencies in the US is known as a USDMF. Cisatracurium USDMF includes data on Cisatracurium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cisatracurium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cisatracurium suppliers with USDMF on PharmaCompass.
A Cisatracurium CEP of the European Pharmacopoeia monograph is often referred to as a Cisatracurium Certificate of Suitability (COS). The purpose of a Cisatracurium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cisatracurium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cisatracurium to their clients by showing that a Cisatracurium CEP has been issued for it. The manufacturer submits a Cisatracurium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cisatracurium CEP holder for the record. Additionally, the data presented in the Cisatracurium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cisatracurium DMF.
A Cisatracurium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cisatracurium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cisatracurium suppliers with CEP (COS) on PharmaCompass.
A Cisatracurium written confirmation (Cisatracurium WC) is an official document issued by a regulatory agency to a Cisatracurium manufacturer, verifying that the manufacturing facility of a Cisatracurium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cisatracurium APIs or Cisatracurium finished pharmaceutical products to another nation, regulatory agencies frequently require a Cisatracurium WC (written confirmation) as part of the regulatory process.
click here to find a list of Cisatracurium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cisatracurium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cisatracurium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cisatracurium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cisatracurium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cisatracurium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cisatracurium suppliers with NDC on PharmaCompass.
Cisatracurium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cisatracurium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cisatracurium GMP manufacturer or Cisatracurium GMP API supplier for your needs.
A Cisatracurium CoA (Certificate of Analysis) is a formal document that attests to Cisatracurium's compliance with Cisatracurium specifications and serves as a tool for batch-level quality control.
Cisatracurium CoA mostly includes findings from lab analyses of a specific batch. For each Cisatracurium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cisatracurium may be tested according to a variety of international standards, such as European Pharmacopoeia (Cisatracurium EP), Cisatracurium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cisatracurium USP).
Market Place
